The present invention encompasses compounds of formula (I) wherein the groups R1 to R7, A, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.
本发明涵盖了式(I)化合物,其中R1至R7、A、V、W、X、Y、n、r和q等基团的定义如权利要求书中所述,其用作M
DM2-p53相互作用
抑制剂,含有此类化合物的药物组合物,其用作药物,特别是用作治疗和/或预防肿瘤疾病的药剂,以及合成中间体。